A study by the Northwest Minzu University in China has revealed that drinking Coca-Cola and Pepsi can lead to larger testicles and higher testosterone levels.
The university was determining the impact of carbonated beverages on fertility and sexual organs in men.
The study looked at five groups of 30 mice drinking different kinds of beverages for 15 days.
One group drank water, another drank 50 percent Pepsi mixed with tap water, and a third group drank pure Pepsi.
Then a fourth group was given Coke mixed with tap water, and the fifth group drank pure Coke.
The rodents were tested on days one, five, seven, 10, and 15 by weighing their testicles and drawing blood.
The researchers discovered that the mice that drank pure Coca-Cola and Pepsi Cola had higher levels of the male hormone than those that drank water.
Thus, the researchers concluded that drinking Coca-Cola and Pepsi-Cola could promote testis development and enhance testosterone secretion.
They also noted that their findings provide the scientific basis for fully understanding the effects and mechanisms of carbonated beverages on human development and reproductive functions and how they benefit the prevention of prostate dysfunction and cancer.


Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Germany’s Economic Recovery Slows as Trade Tensions and Rising Costs Weigh on Growth
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
BOJ Governor Ueda Highlights Uncertainty Over Future Interest Rate Hikes
Asian Currencies Steady as Rupee Hits Record Low Amid Fed Rate Cut Bets
Asian Markets Stabilize as Wall Street Rebounds and Rate Concerns Ease
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
UPS MD-11 Crash Prompts Families to Prepare Wrongful Death Lawsuit
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban
European Oil & Gas Stocks Face 2026 With Cautious Outlook Amid Valuation Pressure
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 



